English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Romiplostim shown to prevent chemotherapy-induced thrombocytopenia in phase 3 trial
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Study finds treatment gap for young ADHD patients with substance use disorders
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

AI model aims to improve fairness and speed in disaster aid delivery
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Solid Biosciences reports new data for Duchenne gene therapy in Phase 1/2 trial
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Evaluate projects rare disease drug sales to surpass $400 billion by 2032
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Biotechs report regulatory challenges and key catalysts in fourth quarter earnings
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

FDA transparency questioned after official’s anonymous comments on Huntington’s therapy
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Penn experts propose a tobacco playbook for food policy

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes